Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $5.8 million of Shares

GuruFocus.com
0
In this article:

- By insider

Chairman & CEO of Edwards Lifesciences Corp (EW) Michael A Mussallem sold 32,800 shares of EW on 02/12/2019 at an average price of $176.9 a share. The total sale was $5.8 million.

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $37.13 billion; its shares were traded at around $177.59 with a P/E ratio of 52.70 and P/S ratio of 10.48. Edwards Lifesciences Corp had annual average EBITDA growth of 19.90% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 5-star.


CEO Recent Trades:

  • Chairman & CEO Michael A Mussallem sold 32,800 shares of EW stock on 02/12/2019 at the average price of $176.9. The price of the stock has increased by 0.39% since.

Directors and Officers Recent Trades:

  • CVP, Japan & Intercontinental Huimin Wang sold 4,000 shares of EW stock on 02/05/2019 at the average price of $171.68. The price of the stock has increased by 3.44% since.

  • CVP, THV Replacement Larry L Wood sold 6,716 shares of EW stock on 02/04/2019 at the average price of $169.1. The price of the stock has increased by 5.02% since.

  • CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,500 shares of EW stock on 01/16/2019 at the average price of $162.03. The price of the stock has increased by 9.6% since.

  • CVP, Critical Care & Vascular Catherine M. Szyman sold 700 shares of EW stock on 01/15/2019 at the average price of $155. The price of the stock has increased by 14.57% since.

For the complete insider trading history of EW, click here

.This article first appeared on GuruFocus.


Advertisement

Recommended Stories